GALIMBERTI STEFANIA

Ruolo: 
Professore ordinario
Settore scientifico disciplinare: 
STATISTICA MEDICA (MED/01)
Telefono: 
0264488164

Pubblicazioni

  • Soria, A., Galimberti, S., Lapadula, G., Visco, F., Ardini, A., Valsecchi, M., et al. (2021). The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19. PLOS ONE, 16(1 - January 2021). Dettaglio
  • Piga, I., Capitoli, G., Clerici, F., Brambilla, V., Leni, D., Scardilli, M., et al. (2020). Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 1868(11). Dettaglio
  • Magnani, C., Gaipa, G., Lussana, F., Belotti, D., Gritti, G., Napolitano, S., et al. (2020). Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities. THE JOURNAL OF CLINICAL INVESTIGATION. Dettaglio
  • Chinello, C., de Haan, N., Trezzi, B., Capitoli, G., Radice, A., Galimberti, S., et al. (2020). Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy. Intervento presentato a: ASMS 2020 Reboot ('Rebooted' edition of the 68th ASMS Conference on Mass Spectrometry and Allied Topics), 1-12 June 2020, telematico. Dettaglio
  • Rotiroti, M., Buracchi, C., Arcangeli, S., Galimberti, S., Valsecchi, M., Perriello, V., et al. (2020). Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System. MOLECULAR THERAPY, 28(9), 1974-1986. Dettaglio